| TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells SR Krutzik, B Tan, H Li, MT Ochoa, PT Liu, SE Sharfstein, TG Graeber, ... Nature medicine 11 (6), 653-660, 2005 | 591 | 2005 |
| Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania S Kawasaki, E Francis, S Mills, G Buchberger, R Hogentogler, ... Journal of Substance Abuse Treatment 106, 58-64, 2019 | 48 | 2019 |
| Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification SS Kawasaki, JS Jacapraro, DA Rastegar Journal of Substance Abuse Treatment 43 (3), 331-334, 2012 | 42 | 2012 |
| Combination extended smoking cessation treatment plus home visits for smokers with schizophrenia: a randomized controlled trial AL Brody, T Zorick, R Hubert, GS Hellemann, S Balali, SS Kawasaki, ... Nicotine & Tobacco Research 19 (1), 68-76, 2016 | 33 | 2016 |
| ASAM clinical considerations: buprenorphine treatment of opioid use disorder for individuals using high-potency synthetic opioids MB Weimer, AA Herring, SS Kawasaki, M Meyer, BA Kleykamp, ... Journal of addiction medicine 17 (6), 632-639, 2023 | 23 | 2023 |
| Criminal charges prior to and after enrollment in opioid agonist treatment: a comparison of methadone maintenance and office-based buprenorphine DA Rastegar, S Sharfstein Kawasaki, VL King, EE Harris, RK Brooner Substance Use & Misuse 51 (7), 803-811, 2016 | 14 | 2016 |
| The cost of the opioid epidemic, in context S Kawasaki, JM Sharfstein Am J Manag Care 25 (13 Suppl), S241-S242, 2019 | 13 | 2019 |
| A comparison of patients with opioid use disorder receiving buprenorphine treatment with and without peer recovery support services S Mills Huffnagle, G Brennan, K Wicks, D Holden, S Kawasaki Journal of Substance Use 27 (3), 266-271, 2022 | 6 | 2022 |
| The opioid epidemic: Mobilizing an academic health center to improve outcomes S Kawasaki, E Dunham, S Mills, E Kunkel, JD Gonzalo Journal of substance abuse treatment 121, 108199, 2021 | 5 | 2021 |
| Disability-adjusted life-years for drug overdose crisis and COVID-19 are comparable during the two years of pandemic in the United States Q Chen, PM Griffin, SS Kawasaki Value in Health 26 (6), 796-801, 2023 | 3 | 2023 |
| COVID-19-related flexibility in methadone take-home doses associated with decreased attrition: Report from an opioid treatment program in central Pennsylvania SS Kawasaki, R Zimmerman, C Shen, AE Zgierska Journal of Substance Use and Addiction Treatment 155, 209164, 2023 | 2 | 2023 |
| Opioid Overdose Hospitalizations During COVID-19: The Experience of Pennsylvania C Shen, JD Thornton, N Li, S Zhou, L Wang, DL Leslie, SS Kawasaki Substance Use: Research and Treatment 18, 11782218231222343, 2024 | 1 | 2024 |
| Nutritional status differs by prescription opioid use among women of reproductive age: NHANES 1999–2018 EE Hohman, TE Corr, S Kawasaki, JS Savage, D Symons Downs Nutrients 15 (8), 1891, 2023 | 1 | 2023 |
| Preparing for the future of medical education: A case series of traditional and virtual clinical rotations in addiction medicine spanning the COVID pandemic C Bone, N Wendel, SL Leong, B Snyder, H Costigan, J Bowen, J Sell, ... Substance Abuse 43 (1), 884-891, 2022 | 1 | 2022 |
| Collaborative health systems ECHO: The use of a tele-education platform to facilitate communication and collaboration with recipients of state targeted response funds in … S Kawasaki, G Hwang, K Buckner, E Francis, S Huffnagle, ... Substance abuse 43 (1), 892-900, 2022 | 1 | 2022 |
| Characterization of Peer Support Services for Substance Use Disorders in 11 US Emergency Departments in 2020: Findings From a Nida Clinical Trials Network Study Site Selection … A Moreland, L Jennings, L Lander, T Lawdahl, E McClure, J McCauley, ... Drug and Alcohol Dependence 260, 110530, 2024 | | 2024 |
| Geographic Variations in Fentanyl Positive Urine Drug Screens in the United States, 2021 E Winstanley, B Hendricks, J Liebschutz, C Murray-Krezan, J Bertz, Y Liu, ... Drug and Alcohol Dependence 260, 110493, 2024 | | 2024 |
| Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process LK Jennings, L Lander, T Lawdahl, EA McClure, A Moreland, ... Addiction Science & Clinical Practice 19 (1), 26, 2024 | | 2024 |
| Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States C Shen, JD Thornton, N Li, E Schaefer, S Zhou, S Kawasaki, C Pameijer, ... The Oncologist 29 (2), 176-184, 2024 | | 2024 |
| First Response to Opioids Survey Tool (FROST): Pilot study of a brief screening tool to assess opioid use disorder risk SL Mills-Huffnagle, C Morris, S Kawasaki, GE Waverka, HA Hammen, ... Journal of opioid management 20 (3), 197-207, 2024 | | 2024 |
